Use of injectable contraceptives opposed

11/27/2010

0 Comments

 
New Delhi: Nov 27, 2010

Women's organisations and health experts, including a member of the Population Council of India, have impressed upon the Drug Technical Advisory Board (DTAB) to disallow the use of Depot medroxyprogesterone acetate (DMPA) – an injectable contraceptive used in the family planning programme. The DMPA, a progestogen-only contraceptive injected every 3 months, was licensed by the Drugs Controller of India in the 1990s. An intervention petition filed in the matter led to the DTAB restricting its use to private market.The approval itself was based on the manufacturer Max Pharma carrying out post-marketing studies as this injection was not properly researched in India.

Read more
0 Comments



Leave a Reply.

    Health News Update

    Archives

    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    August 2011
    July 2011
    June 2011
    May 2011
    April 2011
    March 2011
    February 2011
    January 2011
    December 2010
    November 2010
    October 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010
    May 2007
    April 2007
    March 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006
    September 2006

    Categories

    All

    RSS Feed